Efficacy News and Research

RSS
Phase-II clinical trial of MLN8237 drug shows promising results for treating ovarian cancer

Phase-II clinical trial of MLN8237 drug shows promising results for treating ovarian cancer

Anti-HER2 antibody-drug conjugate effective as first-line therapy for advanced breast cancer: Research

Anti-HER2 antibody-drug conjugate effective as first-line therapy for advanced breast cancer: Research

Defense Department's AFIRM to fund Stratatech's Phase IIb clinical trial of StrataGraft tissue

Defense Department's AFIRM to fund Stratatech's Phase IIb clinical trial of StrataGraft tissue

Clinical study data on Natural S-equol supplement presented at NAMS Annual Meeting

Clinical study data on Natural S-equol supplement presented at NAMS Annual Meeting

Pfizer announces tasocitinib Phase 2 data for plaque psoriasis

Pfizer announces tasocitinib Phase 2 data for plaque psoriasis

IV ibuprofen effective in reducing fever in hospitalized patients

IV ibuprofen effective in reducing fever in hospitalized patients

VentiRx announces VTX-1463 trial results for allergic rhinitis treatment

VentiRx announces VTX-1463 trial results for allergic rhinitis treatment

Phase 3 study of D-tagatose in Type 2 diabetes shows significant reduction in HbA1c levels

Phase 3 study of D-tagatose in Type 2 diabetes shows significant reduction in HbA1c levels

International scientific conference explores new approaches to prevent infectious diseases

International scientific conference explores new approaches to prevent infectious diseases

Novel peptide NX002 demonstrates efficacy in animal model of oral mucositis: Study

Novel peptide NX002 demonstrates efficacy in animal model of oral mucositis: Study

Medical researchers take the next step in personalized medicine

Medical researchers take the next step in personalized medicine

NIAID awards $6.25M to Profectus to optimize portfolio of genetic adjuvants

NIAID awards $6.25M to Profectus to optimize portfolio of genetic adjuvants

Targacept announces top-line results from AZD1446 Phase 2 clinical trial for ADHD

Targacept announces top-line results from AZD1446 Phase 2 clinical trial for ADHD

Sucampo submits marketing application for Amitiza drug

Sucampo submits marketing application for Amitiza drug

Privigen IVIg therapy effective for primary, secondary immunodeficiencies: Study

Privigen IVIg therapy effective for primary, secondary immunodeficiencies: Study

Hizentra therapy effective for primary immunodeficiency patients

Hizentra therapy effective for primary immunodeficiency patients

Role of TGF-ß in cancer diseases

Role of TGF-ß in cancer diseases

Top research papers on venous disease receive VDC Research Awards

Top research papers on venous disease receive VDC Research Awards

Ferring Pharmaceuticals announces publication of Phase 3 trials of LYSTEDA tablets for HMB

Ferring Pharmaceuticals announces publication of Phase 3 trials of LYSTEDA tablets for HMB

Neoprobe completes pre-NDA assessment for Lymphoseek with FDA

Neoprobe completes pre-NDA assessment for Lymphoseek with FDA

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.